Label: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE - cetirizine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release

  • NDC Code(s): 63868-964-24, 63868-964-73
  • Packager: Chain Drug Marketing Association, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 29, 2016

If you are a consumer or patient please visit this version.

  • Drug Facts
  • Active ingredients


    Cetirizine HCl, USP 5 mg
    Pseudoephedrine HCl, USP 120 mg

    Close
  • Purpose


    Antihistamine
    Nasal Decongestant

    Close
  • Uses

    • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
      • runny nose
      • sneezing
      • itchy, watery eyes
      • itching of the nose or throat
      • nasal congestion
    • reduces swelling of nasal passages
    • temporarily relieves sinus congestion and pressure
    • temporarily restores freer breathing through the nose
    Close
  • Warnings
  • Do not use

    • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (cer tain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
    Close
  • Ask a doctor before use if you have

    • heart disease
    • thyroid disease
    • diabetes
    • glaucoma
    • high blood pressure
    • trouble urinating due to an enlarged prostate gland
    • liver or kidney disease. Your doctor should determine if you need a different dose.
    Close
  • Ask a doctor or pharmacist before use if you are


    taking tranquilizers or sedatives.

    Close
  • When using this product

    • do not use more than directed 
    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery
    Close
  • Stop use and ask a doctor if

    • an allergic reaction to this product occurs. Seek medical help right away.
    • you get nervous, dizzy, or sleepless
    • symptoms do not improve within 7 days or are accompanied by fever
    Close
  • If pregnant or breast-feeding:

    • if breast-feeding: not recommended
    • if pregnant: ask a health professional before use.
    Close
  • Keep out of reach of children.


    In case of overdose, get medical help or contact a Poison Control Center right away.

    Close
  • Directions

    • do not break or chew tablet; swallow tablet whole
    adults and children 12 years and over
        take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours.
    adults 65 years and over
        ask a doctor
    children under 12 years of age
        ask a doctor
    consumers with liver or kidney disease
        ask a doctor
    Close
  • Other information

    • store between 20° to 25°C (68° to 77°F) 
    • do not use if inner safety seal is open or torn
    • see side panel for batch number and expiration date
    Close
  • Inactive ingredients


    hydroxyethyl cellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid, titanium dioxide
    Imprinting Ink Contents: ammonium hydroxide, iron oxide black, isopropyl alcohol, N-butyl alcohol, propylene glycol, shellac glaze

    Close
  • Questions?


    Call toll free 1-800-818-4555 weekdays

    Close
  • Principal Display Panel - Showbox


    NDC 63868-964-24
    *Compare to the active Ingredient in ZYRTEC-D®
    Original Prescription Strength
    Allergy Relief-D
    Cetirizine HCl and Pseudoephedrine HCl Extended-release Tablets, USP
    5 mg/120 mg

    Indoor & Outdoor Allergies

    ALLERGY & CONGESTION
    12 Hour Relief of:
    Sneezing
    Itchy, Watery Eyes
    Runny Nose
    Sinus Pressure 
    Itching Throat or nose
    Nasal Congestion

    DO NOT USE IF INDIVIDUAL BLISTER UNIT IS OPEN OR TORN
    24 Tablets (4 blister cards of 6 tablets each)
    QUALITY CHOICE

    spl-cetrizine-psedoephedrine

    Close
  • INGREDIENTS AND APPEARANCE
    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 
    cetirizine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:63868-964
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE 5 mg
    PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg
    Inactive Ingredients
    Ingredient Name Strength
    HYDROXYPROPYL CELLULOSE (TYPE H) (UNII: RFW2ET671P)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    AMMONIA (UNII: 5138Q19F1X)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    BUTYL ALCOHOL (UNII: 8PJ61P6TS3)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SHELLAC (UNII: 46N107B71O)  
    HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) (UNII: ZYD53NBL45)  
    Product Characteristics
    Color WHITE Score no score
    Shape ROUND (circular) Size 9mm
    Flavor Imprint Code 915
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:63868-964-24 4 in 1 CARTON 03/03/2016
    1 NDC:63868-964-73 6 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    ANDA ANDA090922 03/03/2016
    Labeler - Chain Drug Marketing Association, Inc. (011920774)
    Registrant - Sun Pharmaceutical Industries Limited (650172430)
    Establishment
    Name Address ID/FEI Business Operations
    Sun Pharmaceutical Industries Limited 650445203 ANALYSIS(63868-964) , MANUFACTURE(63868-964)
    Close